• 1
    Hegarty, B. D., Furler, S. M., Ye, J., Cooney, G. J., Kraegen, EW. (2003) The role of intramuscular lipid in insulin resistance. Acta Physiol Scand. 178: 373383.
  • 2
    Kriketos, A. D., Furler, S. M., Gan, S. K., Poynten, A. M., Chisholm, D. J., Campbell, LV. (2003) Multiple indexes of lipid availability are independently related to whole body insulin action in healthy humans. J Clin Endocrinol Metab. 88: 793798.
  • 3
    Furler, S. M., Poynten, A. M., Kriketos, A. D., et al (2001) Independent influences of central fat and skeletal muscle lipids on insulin sensitivity. Obes Res. 9: 535543.
  • 4
    Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., Lodish, HF. (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 270: 2674626749.
  • 5
    Arita, Y., Kihara, S., Ouchi, N., et al (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 257: 7983.
  • 6
    Weyer, C., Funahashi, T., Tanaka, S., et al (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 86: 19301935.
  • 7
    Spranger, J., Kroke, A., Mohlig, M., et al (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet. 361: 226228.
  • 8
    Lindsay, R. S., Funahashi, T., Hanson, R. L., et al (2002) Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 360: 5758.
  • 9
    Fruebis, J., Tsao, T. S., Javorschi, S., et al (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA. 98: 20052010.
  • 10
    Yamauchi, T., Kamon, J., Minokoshi, Y., et al (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 8: 12881295.
  • 11
    Yamauchi, T., Kamon, J., Waki, H., et al (2003) Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem. 278: 24612468.
  • 12
    Iglesias, M. A., Furler, S. M., Cooney, G. J., Kraegen, E. W., Ye, JM. (2004) AMP-activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo. Diabetes. 53: 16491654.
  • 13
    Ouchi, N., Kihara, S., Arita, Y., et al (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation. 102: 12961301.
  • 14
    Poynten, A. M., Gan, S. K., Kriketos, A. D., et al (2003) Nicotinic acid-induced insulin resistance is related to increased circulating fatty acids and fat oxidation but not muscle lipid content. Metabolism. 52: 699704.
  • 15
    Gan, S. K., Kriketos, A. D., Ellis, B. A., Thompson, C. H., Kraegen, E. W., Chisholm, DJ. (2003) Changes in aerobic capacity and visceral fat but not myocyte lipid levels predict increased insulin action after exercise in overweight and obese men. Diabetes Care. 26: 17061713.
  • 16
    Gan, S. K., Samaras, K., Thompson, C. H., et al (2002) Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy. Diabetes. 51: 31633169.
  • 17
    Forouhi, N. G., Jenkinson, G., Thomas, E. L., et al (1999) Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia. 42: 932935.
  • 18
    Kriketos, A. D., Greenfield, J. R., Peake, P. W., et al (2004) Inflammation, insulin resistance, and adiposity; a study of first-degree relatives of type 2 diabetic subjects. Diabetes Care. 27: 20332040.
  • 19
    Furler, S. M., Zelenka, G. S., Kraegen, EW. (1986) Development and testing of a simple algorithm for a glucose clamp. Med Biol Eng Comput. 24: 365370.
  • 20
    Tabachnick, B. G., Fidell, LS. (2001) Using Multivariate Statistics 140144.4th ed, Allyn and Bacon Boston, MA.
  • 21
    Chandran, M., Phillips, S. A., Ciaraldi, T., Henry, RR. (2003) Adiponectin: more than just another fat cell hormone? Diabetes Care. 26: 24422450.
  • 22
    Gan, S. K., Kriketos, A. D., Poynten, A. M., et al (2003) Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity. Obes Res. 11: 12951305.
  • 23
    Stefan, N., Vozarova, B., Funahashi, T., et al (2002) Plasma adiponectin levels are not associated with fat oxidation in humans. Obes Res. 10: 10161020.
  • 24
    Groop, L. C., Bonadonna, R. C., Shank, M., Petrides, A. S., DeFronzo, RA. (1991) Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. J Clin Invest. 87: 8389.
  • 25
    Friedewald, W. T., Levy, R. I., Fredrickson, DS. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18: 499502.
  • 26
    Ng, T. W., Watts, G. F., Farvid, M. S., Chan, D. C., Barrett, PH. (2005) Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics? Diabetes. 54: 795802.
  • 27
    Muoio, D. M., Seefeld, K., Witters, L. A., Coleman, RA. (1999) AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J. 338: 783791.
  • 28
    Kurth-Kraczek, E. J., Hirshman, M. F., Goodyear, L. J., Winder, WW. (1999) 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes. 48: 16671671.
  • 29
    Haffner, SM. (2003) Insulin resistance, inflammation, and the prediabetic state. Am J Cardiol. 92: 18J26J.
  • 30
    Ouchi, N., Kihara, S., Funahashi, T., et al (2003) Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 107: 671674.
  • 31
    Samaras, K., Campbell, LV. (2000) Increasing incidence of type 2 diabetes in the third millennium: is abdominal fat the central issue? Diabetes Care. 23: 441442.
  • 32
    Lafontan, M., Dang-Tran, L., Berlan, M. (1979) Alpha-adrenergic antilipolytic effect of adrenaline in human fat cells of the thigh: comparison with adrenaline responsiveness of different fat deposits. Eur J Clin Invest. 9: 261266.